The Utilisation of Genetic Counselling Services Amongst Prenatal Healthcare Providers in Gauteng, South Africa Authors: Megan Duvenhage, Katryn Fourie, Monica Araujo Published: 2026 ABSTRACT ABSTRACTIntroductionCongenital anomalies and genetic disorders contribute substantially to perinatal morbidity and mortality, particularly in low‐ and middle‐income countries. Prenatal healthcare providers play a key role in identifying affected pregnancies and referring to patients for genetic counselling; however, referral practices remain suboptimal.ObjectiveTo assess the utilisation of genetic counselling services and perceptions of genetic counselling among prenatal healthcare providers in Gauteng Province, South Africa.MethodAn electronic survey was distributed to prenatal healthcare providers working in public and private healthcare sectors in Gauteng. The survey assessed access to genetic counselling services, referral practices, knowledge of referral indications, understanding of the genetic counsellor's role, and perceived barriers to referral. Fifty‐four respondents were included.ResultsSeventy‐four percent of participants reported being able to refer to patients for genetic counselling, but only 57% had utilised the service. No participant correctly identified all appropriate referral indications, and only 24% understood the scope of practice of genetic counsellors. Only 6% felt confident in their knowledge of genetic counselling.ConclusionAlthough genetic counselling services are available and utilised in Gauteng, they are not accessed to their full potential. Improved education and clearer referral guidance are required to optimise prenatal genetic care in this setting.Keywords: attitudes, awareness, education, genetic counselling, prenatal diagnosis, utility Introduction Congenital anomalies remain a significant global and national health concern, affecting approximately 3% of births worldwide and up to 7% of births in South Africa [1, 2]. Despite the high prevalence and associated mortality, up to 70% of congenital disorders can be prevented, ameliorated, or effectively managed through relatively inexpensive interventions [2]. Reducing this burden requires coordinated prevention and care across primary, secondary, and tertiary levels, with prenatal screening and diagnosis forming a critical component of secondary prevention [3]. As up to 80% of congenital abnormalities may be genetic or partially genetic, medical genetic services, including genetic counselling, play a central role in prevention, diagnosis, and management [3]. Genetic counsellors facilitate informed decision‐making by providing patients with comprehensible information on reproductive health, prenatal screening and diagnosis, pregnancy options, and postnatal care. Integration of genetic counselling services within a comprehensive, tiered healthcare framework is therefore recommended to reduce the burden of inherited conditions, while also supporting informed reproductive decision‐making, enhancing patient understanding of available testing options and providing psychosocial support to individuals and families [3, 4, 5, 6, 7]. Genetic counselling is still a young profession within South Africa, with formal clinics in the state healthcare systems in Johannesburg and Cape Town starting in the late 1960s [3, 4]. In South Africa, genetic counselling remains a smaller and unevenly distributed profession, with state‐funded services available in only four of nine provinces, namely Gauteng, the Western Cape, the Free State and Kwa‐Zulu Natal [6]. These services include medical genetics, genetic counselling and genetic testing in prenatal, paediatric and adult settings [8]. These services are also offered in the private sector at various independent and state‐run organisations. Prenatal abnormalities are often first identified by foetal medicine specialists, obstetricians, gynaecologists, or sonographers. Multiple healthcare providers, including foetal medicine specialists and obstetricians, are able to order prenatal genetic testing within their scope of practice. However, genetic counsellors play a key role in supporting appropriate test selection, facilitating informed decision‐making, obtaining informed consent (particularly for invasive procedures), and providing psychological and emotional support [9]. In practice, genetic counsellors frequently work collaboratively with referring prenatal care providers to determine the most appropriate testing strategy, although testing may be initiated without their involvement. Referral to genetic services is therefore recommended to optimise patient understanding, ensure appropriate test utilisation, and support multidisciplinary management of prenatal cases [10, 11]. There are currently fewer than 30 registered and practicing genetic counsellors in South Africa, with only 5 employed in the Clinical and Counselling Unit of the Division of Human Genetics at the National Health Laboratory Service (NHLS) and the University of the Witwatersrand and utilisation of available services is believed to be low (K. Fourie, personal communication, October 12, 2023). Improving service provision and patient management requires a clearer understanding of factors influencing referral and utilisation [5, 6, 12]. Previous international and local studies have shown that healthcare professionals outside the field of genetics often have limited awareness of genetic counselling services and the role of genetic counsellors, resulting in underutilisation [12, 13, 14]. Not only do practitioners have insufficient genetics knowledge, but they also need to be made aware of the types of patients eligible for referral to genetic services [15]. In South Africa, Thom and Haw demonstrated poor awareness of genetic counselling services and referral pathways among allied healthcare professionals, findings consistent with international literature [12, 13, 15, 16]. However, these results may not be directly applicable to prenatal healthcare providers, whose training, scope of practice and role in antenatal care differ substantially. This study therefore aimed to assess the utilisation of genetic counselling services among prenatal healthcare providers in Gauteng, South Africa, and to explore their perceptions of genetic counselling and its perceived value in prenatal care. By identifying patterns of utilisation and perceived barriers, this study sought to inform recommendations to improve the delivery and integration of genetic counselling services within the prenatal sector in Gauteng, South Africa. Methods Participants Eligible participants were Gauteng‐based prenatal healthcare professionals practising as foetal medicine specialists, obstetricians, gynaecologists, sonographers, midwives, or fertility specialists. Registrars and medical officers (MOs) with more than 6 months of training in these fields were also included. Recruitment was conducted via email containing a link to the online survey, participant information, and informed consent, distributed through departmental heads at participating state hospitals, professional organisational databases, and directly to private practitioners. Additional recruitment occurred during departmental meetings attended by the researcher. Snowball sampling was used by requesting recipients to forward the study invitation to other eligible providers. All participants provided informed consent prior to participation, and responses were anonymous. Ethical clearance was obtained from the Human Research Ethics Committee (Medical) of the University of the Witwatersrand (Certificate no. M230268). Instrumentation The survey (Supporting Information S1) was adapted from a questionnaire developed by Thom and Haw [12] assessing awareness of genetic counselling services among allied healthcare professionals in South Africa. Although their study population differed, the survey addressed similar aims regarding awareness and utilisation of genetic counselling services. Items were modified to ensure relevance to prenatal healthcare practice. The questionnaire was administered electronically using Google Forms, and all items were mandatory to minimise incomplete submissions. The survey comprised three sections: (1) participant demographics and professional practice characteristics, (2) referral practices to genetic counselling services and (3) knowledge and understanding of genetic counselling services. The survey included a combination of single‐response items, multiple‐response checkbox items, Likert‐style matrix questions, and free‐text responses. The content addressed participants' professional background and setting of practice, referral behaviour, knowledge of indications for referral, understanding of the role and recognised fields of practice of genetic counsellors, perceived barriers to referral, and preferences for further genetics education. Data Analysis Participants were categorised according to their primary professional role. Where multiple roles were reported, the role requiring the highest level of specialised training was assigned. Obstetricians and gynaecologists were grouped under ‘OBGYN’. Descriptive statistics, including means and standard deviations, frequencies, and proportions, were generated using Microsoft Excel to summarise participant characteristics, referral practices, and knowledge of genetic counselling services. The number of referrals reported by participants was treated as a continuous variable. One‐way analysis of variance (ANOVA) was used to assess whether mean referral numbers differed across professional groups. Data were normally distributed, and no statistically significant differences were observed in years of practice (p = 0.71) or number of referrals between groups (p = 0.13). Given the absence of statistically significant differences and the relatively small sample size, further analyses were conducted on the cohort as a whole. Subgroup comparisons presented in the Results are descriptive in nature and were not subjected to formal statistical testing. Categorical variables were summarised using frequencies and percentages. No inferential statistical tests (e.g., chi‐square or Fisher's exact tests) were performed for categorical subgroup comparisons due to small subgroup sizes and limited statistical power. Free‐text responses were reviewed and summarised descriptively. Similar responses were grouped together to identify commonly and less commonly reported answers. No formal qualitative coding or thematic analysis was undertaken. Results Participant Characteristics A total of 54 prenatal healthcare providers in Gauteng were recruited through multiple channels, including six state hospitals, professional mailing lists, and private practices. These recruitment pathways were used to capture participants working across both public and private sector settings. Participant demographic and professional characteristics are summarised in Table 1. The majority of participants were medical practitioners working in obstetrics and gynaecology (59.2%), with over half practising exclusively in the state healthcare sector. TABLE 1The demographic data of the responses included in the study.CharacteristicsMean ± SD or number (%)Age (years)42.4 ± 10.6Number of respondentsFoetal medicine specialist8 (14.8%)Midwives11 (20.4%)OBGYN32 (59.2%)Sonographers3 (5.6%)Area of practicePrivate only13 (24.1%)State only31 (57.4%)Private and state10 (18.5%)Years in current profession< 518 (33.3%)5–1014 (25.9%)10–157 (13.0%)> 1515 (27.8%) The demographic data of the responses included in the study. Referrals to Genetic Counselling Services Most participants (74.1%) reported that they were able to refer patients to genetic counselling services, while the remainder reported being unable to refer, uncertain about referral availability, or considered referrals outside their scope of practice. Just over half of the participants (57.3%) had referred to at least one patient to genetic counselling in the 3 months preceding participation. Referral rates, measured as the number of referrals reported, did not differ significantly between medical practitioners (foetal medicine specialists and obstetricians/gynaecologists) and allied prenatal healthcare professionals (sonographers and midwives) (one‐way ANOVA, p > 0.05) (Figure 1). A summary of the number of referrals made to genetic counselling services over the 3 months prior to participation in the study. Participants demonstrated limited knowledge of appropriate indications for referral to genetic counselling. Knowledge was operationalised as the number of correctly identified indications from a list of 18 appropriate referral indications. These indications were adapted from a previously published study assessing similar outcomes and were refined during the development and pilot testing of the questionnaire to ensure clarity and contextual relevance. No composite knowledge categories were predefined; results are therefore presented descriptively based on the number of correct responses selected. None of the participants correctly identified all 18 appropriate referral indications, and 20.4% (11/54) identified at least half (≥ 9/18) of the correct indications. This threshold is presented for descriptive purposes to provide an indication of relative performance rather than as a defined benchmark of adequacy. Overall, responses showed a wide distribution in the number of correctly identified indications, suggesting variability in knowledge across participants. Descriptively, a greater proportion of obstetricians/gynaecologists and foetal medicine specialists identified at least half of the appropriate indications compared with midwives and sonographers. The most recognised indication for referral was a previous child with a known genetic condition, while in vitro fertilisation and pre‐implantation counselling was least frequently identified as an appropriate indication (Figure 2). The number of prenatal healthcare providers that identified each reason for referral to genetic counselling services. Options not provided on the survey but listed as an additional answer by participants are denoted with **. Understanding and Knowledge of Genetic Counselling Services Knowledge of the Scope of Practice of Genetic Counsellors When presented with eight potential responsibilities of a genetic counsellor, 75.9% (41/54) of participants were unable to correctly identify the five appropriate responsibilities. The most identified responsibility was ‘to help people understand their options for genetic testing’ (94.4%, 51/54). The three responsibilities that fell outside the scope of practice were selected by a notable proportion of participants, ranging from 18.5% (10/54) to 38.9% (21/54) (Figure 3). The number of prenatal healthcare providers that identified each responsibility as being part of a genetic counsellor's scope of practice. Responsibilities outside the scope of practice of a genetic counsellor are denoted with **. Knowledge of the Fields of Practice of Genetic Counsellors Knowledge of the fields of practice of genetic counsellors was comparatively higher. Fewer than one‐quarter of the participants correctly identified the full scope of practice and responsibilities of a genetic counsellor, whereas 44.4% correctly identified the health care fields where genetic counsellors commonly practice, for example, oncology or paediatrics. Prenatal care was almost universally recognised, whereas other fields, including haematology, were less consistently identified. Barriers and Facilitators to Referrals to Genetic Counselling Services Factors influencing referral decisions and barriers to referral are summarised in Tables 2 and 3. The severity of a suspected or confirmed condition was identified as an important factor in referral decision‐making by nearly all participants. Patient interest in being referred was also commonly reported as influential. The most frequently reported barrier to referral was a lack of awareness of available genetic counselling services. Although participants demonstrated limited knowledge of genetic counselling and referral indications, and few reported confidence in their knowledge, lack of knowledge was infrequently identified as a perceived barrier to referral. This suggests a potential disconnect between participants' self‐reported confidence and their recognition of knowledge limitations. TABLE 2Factors influencing prenatal healthcare providers' decision to refer to patients for genetic counselling.Very important/importantModerately importantOf little importance/unimportantPatients interest in genetic counselling42/54 (77.8%)10/54 (18.5%)2/54 (3.7%)Severity of the disorder52/54 (96.3%)1/54 (1.9%)1/54 (1.9%)Availability of testing and turnaround times46/54 (85.1%)6/54 (11.1%)2/54 (3.7%)Availability of treatment for the disorder40/54 (74.1%)10/54 (18.5%)4/54 (7.4%)Desire for management recommendations49/54 (90.7%)5/54 (9.3%)0/54 (0.0%)Family's desire for recurrence information49/54 (90.7%)5/54 (9.3%)0/54 (0.0%) Factors influencing prenatal healthcare providers' decision to refer to patients for genetic counselling. TABLE 3Factors preventing prenatal healthcare providers' decision to refer patients for genetic counselling.Very frequently/frequentlyOccasionallyRarely/neverWas not aware of genetic services21/54 (38.9%)11/54 (20.4%)22/54 (40.7%)Do not know how to refer patients17/54 (31.5%)14/54 (25.9%)23/54 (42.6%)Do not see much benefit for the patient9/54 (16.7%)15/54 (27.8%)30/54 (55.6%)Do not understand what genetic counsellors do13/54 (24.1%)6/54 (11.1%)35/54 (64.8%)Unable to get appropriate information from the genetic clinic8/54 (14.8%)16/54 (29.6%)30/54 (55.6%)Do not feel it is my responsibility to refer11/54 (20.4%)5/54 (9.3%)38/54 (70.4%) Factors preventing prenatal healthcare providers' decision to refer patients for genetic counselling. Knowledge Improvement Only a small proportion of participants reported feeling sufficiently knowledgeable about genetic counselling (5.6%, 3/54; one obstetrician‐gynaecologist and two foetal medicine specialists). The majority (85.2%, 46/54) expressed interest in further education on genetics and genetic counselling. The most commonly reported area of interest was an overview of genetic disorders encountered in foetal medicine practice (66.7%, 36/54). Over half of the participants indicated interest in identifying relevant genetic resources for patients and learning about new genetic technologies and advances (57.4%, 31/54). Nearly half requested additional education on referral procedures (46.3%, 25/54), while 38.9% (21/54) were interested in learning more about the role and scope of genetic counselling. Online resources were the most preferred modality for knowledge improvement (75.9%, 41/54), followed by academic lectures (59.3%, 32/54), written materials (33.3%, 18/54), and discussion‐based formats (31.5%, 17/54). Discussion This study examined the utilisation of genetic counselling services among prenatal healthcare providers in Gauteng, South Africa, and explored their knowledge of, and attitudes towards, genetic counselling. Although most participants reported being able to refer patients to genetic counselling services, utilisation remained limited. Knowledge gaps regarding referral indications and the scope of genetic counselling practice were also identified. These findings may indicate that knowledge limitations could be one of several factors influencing referral behaviour; however, causal relationships cannot be inferred from this descriptive study design. Referral Patterns and Utilisation Nearly three‐quarters of participants reported having access to referral pathways, whereas just over half had referred to a patient within the 3 months preceding participation. Although obstetricians and gynaecologists accounted for the majority of referrals, overall referral volumes were low. This mirrors findings from other settings, where obstetricians make greater use of genetic services than other specialities, yet overall utilisation remains modest [11, 12, 13]. These findings suggest that, despite relatively good awareness of genetic counselling services within prenatal care compared with other medical fields, referrals do not fully reflect the potential clinical need. Using 2021 census data, roughly 16,937 babies are born in Gauteng per month [17]. This means that there would be approximately 1129 babies born in the province per month that are affected by a congenital abnormality. In the six‐month period that referrals assessed by the study could have occurred, roughly 6770 affected babies would have been born yet the genetics department at the NHLS only saw 173 new prenatal cases (K. Fourie, personal communication, October 12, 2023). While this discrepancy is notable, it should be interpreted with caution. Not all congenital anomalies are detectable prenatally, and therefore not all affected pregnancies would be expected to result in referral to prenatal genetic counselling services. In addition, referral patterns may be influenced by case severity, diagnostic resources, and access to prenatal screening. Nevertheless, these findings may suggest that a proportion of eligible cases are not being referred for genetic counselling, highlighting the potential for underutilisation of services within the public sector. Knowledge of Referral Processes and Indications Despite most participants reporting access to referral pathways, a substantial proportion indicated uncertainty regarding the availability of genetic services or the referral process. This suggests that structural access alone is insufficient to ensure appropriate utilisation. Compared with allied healthcare professionals in previous South African studies [12], prenatal healthcare providers demonstrated greater awareness of genetic services; however, this awareness did not appear to consistently translate into reported referral behaviour. This gap was most evident in participants' limited ability to identify appropriate referral indications. None of the participants correctly identified all listed indications, and only a minority identified at least half. Although foetal medicine specialists and obstetricians performed better than other groups, overall knowledge remained limited, and this study was not powered to formally compare professional groups. These findings may suggest that referrals may be driven by a narrow set of familiar indications rather than a comprehensive understanding of when genetic counselling may be beneficial. Perceptions of Severity and Appropriateness of Referral Participants placed substantial emphasis on the perceived severity of a condition when deciding whether to refer for genetic counselling. Reliance on severity as a primary referral criterion may be problematic, as severity is inherently subjective and lacks clear clinical, legal or psychological and social thresholds [18, 19]. This approach risks excluding patients who may benefit from genetic counselling despite the absence of overt foetal anomalies or clearly defined ‘severe’ conditions [18, 20]. Furthermore, an emphasis on severity may overlook the psychological and emotional dimensions of genetic risk and uncertainty, as well as conditions with variable or delayed phenotypic expression. Many genetic conditions, including common aneuploidies and multifactorial anomalies, may not be detectable prenatally or may present with a wide spectrum of outcomes [20, 21]. In these contexts, genetic counselling plays an important role in supporting patient understanding, managing uncertainty, and facilitating informed decision‐making, rather than solely addressing conditions perceived as severe [20]. Participants appropriately recognised family history and previous affected children as important referral indications; however, this emphasis may reinforce misconceptions about the genetic basis of congenital anomalies. Many anomalies arise sporadically or through de novo variants and may occur in the absence of a family history [22, 23, 24, 25]. It is also important to note that in most cases, carriers of recessive conditions, such as cystic fibrosis, will have no family history of the condition [26]. Restricting referrals to cases with known familial risk may therefore limit access to genetic counselling for a substantial proportion of patients who could benefit from the service. Understanding the Scope and Value of Genetic Counselling Although many participants recognised the role of genetic counsellors in explaining genetic testing options, most were unable to accurately identify the full scope of genetic counselling practice. This discrepancy between perceived and actual knowledge may suggest overestimation of understanding. In particular, the psychological and emotional support components of genetic counselling were under‐recognised. Evidence suggests that pre‐ and post‐termination genetic counselling sessions for foetal anomalies may improve the individuals' ability to cope better with long‐term grief [27]. This further highlights the misconceptions regarding the benefits of referring to a patient for genetic counselling regardless of the pregnancy outcome. A study by Godino et al. [28] showed that invasive testing is still preferred over non‐invasive screening among women of advanced maternal age. This highlights the importance of ensuring that patients are supplied with the correct information to allow this type of decision‐making [27, 28]. Similar points were made in a study by Salema et al. [29], where patients who had received high‐risk prenatal screening results emphasized the importance of the information and guidance provided by their genetic counsellor. However, the same study highlighted the potential for when referrals occur without adequate explanation as to what the role of a genetic counsellor is and why the patient was being referred [29]. Together, these findings reinforce the importance of a comprehensive understanding of the role of genetic counselling. Limited understanding of the scope of genetic counselling may have important implications for referral behaviour. Participants frequently considered patient interest when deciding whether to refer; however, patient awareness of genetic counselling is likely to be limited, particularly in low‐ and middle‐income settings. Without adequate explanation from healthcare providers, patients may not recognise the value of referral, which may contribute to missed opportunities for counselling that supports informed and shared decision‐making. These findings highlight the potential value of improving prenatal healthcare providers' understanding of the role and scope of genetic counselling [30]. Barriers and Facilitators to Referral Although fewer participants identified lack of knowledge as a barrier to referral, performance on knowledge‐based questions suggests that this barrier may be under‐recognised. Barriers to referral were variable across participants. While lack of awareness of available genetic counselling services was the most frequently reported barrier, a substantial proportion of participants (31.5%) reported frequently not knowing how to refer patients. This represents a more concrete, operational barrier and highlights potential gaps in referral processes and system navigation. In addition, although many providers recognised the informational role of genetic counsellors, few acknowledged their role in offering psychological and emotional support. This may reflect a partial understanding of the scope of genetic counselling practice, which could influence referral behaviour. Genetic counsellors provide a holistic approach to patient care through in‐depth discussions with patients not only about the genetic condition at hand, but also about the emotional toll the situation may take on the patient and their family [31]. The effective communication and informed shared decision‐making needed in the prenatal sector should be provided by a genetic counsellor [32]. The importance of support from genetic counsellors was demonstrated in a study by Voorwinden et al. [33], who found that patients who received one‐on‐one genetic counselling or in a group showed significant improvement in personal empowerment, personal control and anxiety. Conversely, the high level of interest in further education represents an important facilitator for improving utilisation [32, 34]. Targeted educational interventions, including clear guidance on referral pathways and the role of genetic counsellors, may support a more appropriate and consistent use of genetic counselling services. Ensuring that such education is accessible across different stages of clinical training may be particularly beneficial [11]. Implications for Practice and Education Given the limited number of genetic counsellors available in Gauteng, improving utilisation cannot rely solely on expanding specialist services. Prenatal healthcare providers require sufficient foundational knowledge to identify appropriate referral scenarios and to explain the purpose and benefits of genetic counselling to patients. However, the implementation of educational interventions may be constrained by practical barriers, including time limitations within busy clinical schedules, variability in baseline genetics knowledge across professional groups, and limited access to structured training opportunities, particularly within resource‐constrained settings. Improving provider education may help to support more appropriate referral practices, strengthen multidisciplinary collaboration, and improve the quality of prenatal care. The strong preference for online educational resources identified in this study suggests an opportunity to deliver scalable and flexible training that can be integrated at multiple stages of professional development. Evidence from the broader literature supports the effectiveness of online and asynchronous learning modalities for healthcare professionals, with systematic reviews demonstrating that e‐learning is increasingly integrated into medical curricula and is associated with positive learning outcomes in clinical education contexts [35]. Case‐based and clinically oriented digital learning approaches further enhance learner engagement and improve the perceived applicability of knowledge to clinical practice, with recent evidence highlighting their growing use and acceptability in medical education settings [36]. Embedding genetics education across undergraduate, postgraduate, and continuing professional development frameworks may further support sustained knowledge acquisition and reinforcement over time, aligning with broader models of continuous medical education that emphasise iterative learning throughout a clinician's professional lifecycle [37]. Study Limitations This study was conducted in a single province with established genetic services and included a relatively small sample size, which may limit generalisability to other settings. As a cross‐sectional survey, findings reflect self‐reported practices and perceptions at a single time point and may be subject to recall or social desirability bias. Selection bias is possible, as participants with prior awareness of genetic services may have been more likely to respond, and private‐sector practitioners with access to in‐house genetic counsellors may be underrepresented. Additionally, the survey instrument has not been formally validated in this population. Despite these limitations, the study identifies consistent knowledge gaps and misconceptions that are likely to be relevant across similar healthcare settings. Practice and Research Recommendations Improved education of prenatal healthcare providers on genetics, appropriate referral indications, and the scope of genetic counselling practice is recommended to support optimal utilisation of genetic counselling services. Such training should be incorporated throughout undergraduate education, postgraduate training, and continuing professional development to ensure knowledge remains current and clinically relevant. Further research assessing utilisation of genetic counselling services across other South African provinces is warranted to determine national referral patterns and identify areas where targeted educational interventions are most needed. Follow‐up studies evaluating referral practices after the implementation of educational initiatives, as well as qualitative research exploring healthcare providers' perceptions of genetic counselling across the preconception, prenatal and postnatal periods, may provide additional insight into barriers to referral and inform more effective integration of genetic counselling into prenatal care. Conclusions This study demonstrates that while prenatal healthcare providers in Gauteng are generally aware of genetic counselling services, utilisation remains suboptimal. Limited understanding of referral indications, referral processes, and the scope of genetic counselling practice appears to contribute to this underutilisation. Encouragingly, most participants expressed interest in further education. Targeted, ongoing training on genetics and genetic counselling has the potential to improve appropriate referral practices, enhance multidisciplinary collaboration, and strengthen the quality of prenatal care. Funding The authors have nothing to report. Ethics Statement The study was approved by the University of the Witwatersrand Ethics Committee (Medical) (Certificate No. M230268). Consent Participants had to sign a consent form before they could participate in the study. The data collected were kept confidential and only accessible by the authors of the study. Conflicts of Interest The authors declare no conflicts of interest. Animal Studies The authors have nothing to report. Supporting information Supporting Information S1 Acknowledgements The authors would like to thank the organisations that agreed to let the authors utilise their mailing lists for participant recruitment. A special thank you is extended to the prenatal healthcare workers who voluntarily set aside time to participate and share their insights. The authors thank Professor Michael Urban for playing a crucial role in the conception and execution of the ISPD conference for which this special issue was published. This study was completed in partial fulfilment of the requirements for the Megan Duvenhage's Master of Science (in Medicine) in Genetic Counselling degree from the University of the Witwatersrand in Johannesburg. The degree and, therefore, study were funded by a postgraduate merit award from the University of the Witwatersrand. Data Availability Statement In compliance with the University of the Witwatersrand Ethics Committee (Medical) privacy restrictions, while no self‐identifying information was asked, to protect the privacy of the research participants none of the study data is publicly available. References Associated Data Supplementary Materials Supporting Information S1 Data Availability Statement In compliance with the University of the Witwatersrand Ethics Committee (Medical) privacy restrictions, while no self‐identifying information was asked, to protect the privacy of the research participants none of the study data is publicly available.